Belite Bio (BLTE) Accumulated Expenses (2021 - 2025)

Belite Bio has reported Accumulated Expenses for 5 years, with the latest figure at $9.6 million in Q4 2025.

• For the quarter ending Q4 2025, Accumulated Expenses rose 67.26% year-over-year to $9.6 million; the trailing twelve-month figure through Dec 2025 stood at $9.6 million (up 67.26% YoY), and the FY2025 full-year result was $9.6 million, up 67.26% from the prior year.
• Accumulated Expenses for Q4 2025 stood at $9.6 million, up from $5.8 million in the prior quarter.
• The five-year high for Accumulated Expenses was $9.6 million in Q4 2025, with the low at $56000.0 in Q4 2021.
• Average Accumulated Expenses over 5 years is $3.8 million, with a median of $3.3 million recorded in 2023.
• Year-over-year, Accumulated Expenses surged 770.42% in 2023 and jumped 67.26% in 2025.
• Tracing BLTE's Accumulated Expenses over 5 years: stood at $56000.0 in 2021, then surged by 582.14% to $382000.0 in 2022, then surged by 770.42% to $3.3 million in 2023, then soared by 73.26% to $5.8 million in 2024, then jumped by 67.26% to $9.6 million in 2025.
• The last three Accumulated Expenses figures came in at $9.6 million (Q4 2025), $5.8 million (Q4 2024), and $3.3 million (Q4 2023), per Business Quant data.

Peer Comparison